Helicates meet Rotaxanes to create promise for future disease treatment
A new approach to treating cancers and other diseases that uses a mechanically interlocked molecule as a ‘magic bullet’ has been designed by researchers at the University of Birmingham. Called rotaxanes, the molecules are tiny nanoscale structures that resemble...Work completes on new railway research centre at the University of Birmingham
A new purpose-built centre designed to deliver specialist research in digital railway engineering has been opened at the University of Birmingham. The Centre of Excellence for Digital Systems showcases successful collaboration between academia and industry, as the...Funding boost for AI-based epilepsy monitoring
University spinout company Neuronostics has received funding to develop its BioEP platform, an AI-based system for faster, more accurate diagnosis of epilepsy and to monitor response to treatment with anti-epileptic drugs (AEDs). BioEP works by creating...
£10.8m investment kick-starts life sciences development in Birmingham
Birmingham Health Innovation Campus (BHIC) has been announced as one of eight ‘shovel ready’ projects in the West Midlands which will benefit from a combined £66 million of Government funding. BHIC will sit at the heart of a critical cluster of health excellence...
Birmingham spinout announces collaboration and licence agreement to develop precision cancer treatments
Birmingham spinout Revitope Oncology Inc has announced a research collaboration and licence agreement with leading Chinese biopharmaceutical company Junshi Biosciences to develop precision cancer therapies that harness the body’s immune response to kill cancer cells...
